Thank you for your interest in PlantForm. Please continue to check back for future hiring opportunities.
We also welcome you to follow PlantForm developments on Twitter, LinkedIn and Facebook.
» March 20, 2023
PlantForm and UBC researcher receive GlycoNet funds to develop novel treatment for Type-2 diabetes
» March 7, 2023
PlantForm, Bio-Manguinhos/Fiocruz sign new agreement to develop biosimilar pembrolizumab cancer drug and additional products
I would like to receive the following updates:
Quarterly Update newsletter
Our process offers several advantages over the mammalian and bacterial cell culture systems used to produce most recombinant protein pharmaceuticals, including:
© 2023 PlantForm